Alcorcon

Spain

60 total trials 31 recruiting

Filter these 60 trials by phase, condition, sponsor and more.

Open in Search →

Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended recruitment

2023-510390-33-00 5 2020-10-23 HER2-negative breast cancer patients with high relapse risk after stan
Long-term study to assess the safety and efficacy of Nemolizumab in subjects with Atopic Dermatitis Ended recruitment

2024-514404-13-00 5 2020-10-01 Atopic Dermatitis
PALLAS - PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy vers … Ended recruitment

2024-514841-12-00 5 2015-10-27 To determine whether the addition of palbociclib to adjuvant endocrine
A 14-week, multicentre, double-blind, randomised, placebo-controlled phase II study with an 8-week treatment period to assess the efficacy a … Ended

2024-513104-34-00 4 2024-11-25 Major Depressive Disorder
A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe … Ended

2024-511363-28-00 5 2024-09-24 hidradenitis suppurativa (HS)
Dose-response characterization of VER-01 in the treatment of patients with chronic non-specific low back pain Ended

2023-507358-34-00 4 2024-02-13 For the treatment of patients with chronic non-specific low back pain
Clinical Trial to Evaluate the Safety and Appropriateness of Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir A … Ended

2024-511951-16-00 6 2022-08-30 HIV
DTG/3TC vs BIC/FTC/TAF maintenance therapy in people living with HIV: an open-label randomized clinical trial Ended

2024-515167-56-00 11 2021-06-22 HIV
Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin … Ended

2023-510230-84-00 5 2021-05-28 Severe asthma with an eosinophilic phenotype
A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tolerability of the investigational product … Ended

2024-512123-37-00 5 2021-05-27 Parkinson's disease
An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Sev … Ended

2022-502361-15-00 5 2019-12-12 Moderate-to-Severe Plaque Psoriasis
Simvastatin in the Prevention of Recurrent Pancreatitis, a Triple Blind, Randomized Controlled Trial. Ended

2024-513188-17-03 6 Recurrent pancreatitis

Showing 49–60 of 60 trials